Genetic and Transcriptional Contributions to Relapse in Normal Karyotype Acute Myeloid Leukemia

por Petti, Allegra A., Khan, Saad M., Xu, Ziheng, Helton, Nichole, Fronick, Catrina C., Fulton, Robert, Ramakrishnan, Sai M., Nonavinkere Srivatsan, Sridhar, Heath, Sharon E., Westervelt, Peter, Payton, Jacqueline E., Walter, Matthew J., Link, Daniel C., DiPersio, John, Miller, Christopher, Ley, Timothy J.
Publicado 2022

Luminescent threat: toxicity of light stick attractors used in pelagic fishery

por de Oliveira, Tiago Franco, da Silva, Amanda Lucila Medeiros, de Moura, Rafaela Alves, Bagattini, Raquel, de Oliveira, Antonio Anax Falcão, de Medeiros, Marisa Helena Gennari, Di Mascio, Paolo, de Arruda Campos, Ivan Pérsio, Barretto, Fabiano Prado, Bechara, Etelvino José Henriques, de Melo Loureiro, Ana Paula
Publicado 2014

A multiple myeloma-specific capture sequencing platform discovers novel translocations and frequent, risk-associated point mutations in IGLL5

por White, Brian S., Lanc, Irena, O’Neal, Julie, Gupta, Harshath, Fulton, Robert S., Schmidt, Heather, Fronick, Catrina, Belter, Edward A., Fiala, Mark, King, Justin, Ahmann, Greg J., DeRome, Mary, Mardis, Elaine R., Vij, Ravi, DiPersio, John F., Levy, Joan, Auclair, Daniel, Tomasson, Michael H.
Publicado 2018

CS1 CAR-T targeting the distal domain of CS1 (SLAMF7) shows efficacy in high tumor burden myeloma model despite fratricide of CD8+CS1 expressing CAR-T cells

por O’Neal, Julie, Ritchey, Julie K., Cooper, Matthew L., Niswonger, Jessica, Sofía González, L., Street, Emily, Rettig, Michael P., Gladney, Susan W., Gehrs, Leah, Abboud, Ramzi, Prior, Julie L., Haas, Gabriel J., Jayasinghe, Reyka G., Ding, Li, Ghobadi, Armin, Vij, Ravi, DiPersio, John F.
Publicado 2022

Recurrent DNMT3A Mutations in Patients with Myelodysplastic Syndromes

por Walter, Matthew J., Ding, Li, Shen, Dong, Shao, Jin, Grillot, Marcus, McLellan, Michael, Fulton, Robert, Schmidt, Heather, Kalicki-Veizer, Joelle, O’Laughlin, Michelle, Kandoth, Cyriac, Baty, Jack, Westervelt, Peter, DiPersio, John F., Mardis, Elaine R, Wilson, Richard K., Ley, Timothy J., Graubert, Timothy A.
Publicado 2011

Health outcomes, education, healthcare delivery and quality – 3051. Profiles of diagnosis and treatment of asthma in the public health system in Brazil

por Melo, Janaina M, Moreno, Adriana S, Ferriani, Virginia PL, Vianna, Elcio, Borges, Marcos, Roxo, Persio, Araujo, Ana Carla S, Mello, Luane M, Ferreira, Rosa, Silva, Jorgete M, Stefanelli, Patricia, Gonçalves, Marcos R, Oliveira, Larissa P, Cetlin, Andrea, Queiroz, Luana B, Villela, Rosangela, Aragon, Davi C, Arruda, L Karla
Publicado 2013

F11R Is a Novel Monocyte Prognostic Biomarker for Malignant Glioma

por Pong, Winnie W., Walker, Jason, Wylie, Todd, Magrini, Vincent, Luo, Jingqin, Emnett, Ryan J., Choi, Jaebok, Cooper, Matthew L., Griffith, Malachi, Griffith, Obi L., Rubin, Joshua B., Fuller, Gregory N., Piwnica-Worms, David, Feng, Xi, Hambardzumyan, Dolores, DiPersio, John F., Mardis, Elaine R., Gutmann, David H.
Publicado 2013

SciClone: Inferring Clonal Architecture and Tracking the Spatial and Temporal Patterns of Tumor Evolution

por Miller, Christopher A., White, Brian S., Dees, Nathan D., Griffith, Malachi, Welch, John S., Griffith, Obi L., Vij, Ravi, Tomasson, Michael H., Graubert, Timothy A., Walter, Matthew J., Ellis, Matthew J., Schierding, William, DiPersio, John F., Ley, Timothy J., Mardis, Elaine R., Wilson, Richard K., Ding, Li
Publicado 2014

Radionuclides transform chemotherapeutics into phototherapeutics for precise treatment of disseminated cancer

por Kotagiri, Nalinikanth, Cooper, Matthew L., Rettig, Michael, Egbulefu, Christopher, Prior, Julie, Cui, Grace, Karmakar, Partha, Zhou, Mingzhou, Yang, Xiaoxia, Sudlow, Gail, Marsala, Lynne, Chanswangphuwana, Chantiya, Lu, Lan, Habimana-Griffin, LeMoyne, Shokeen, Monica, Xu, Xinming, Weilbaecher, Katherine, Tomasson, Michael, Lanza, Gregory, DiPersio, John F., Achilefu, Samuel
Publicado 2018

Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19

por Xiang, Jingyu, Lu, Mijia, Shi, Min, Cheng, Xiaogang, Kwakwa, Kristin A., Davis, Jennifer L., Su, Xinming, Bakewell, Suzanne J., Zhang, Yuexiu, Fontana, Francesca, Xu, Yalin, Veis, Deborah J., DiPersio, John F., Ratner, Lee, Sanderson, Ralph D., Noseda, Alessandro, Mollah, Shamim, Li, Jianrong, Weilbaecher, Katherine N.
Publicado 2022

Impact of JAK Inhibitors in Pediatric Patients with STAT1 Gain of Function (GOF) Mutations—10 Children and Review of the Literature

por Deyà-Martínez, Angela, Rivière, Jaques G., Roxo-Junior, Pérsio, Ramakers, Jan, Bloomfield, Markéta, Guisado Hernandez, Paloma, Blanco Lobo, Pilar, Abu Jamra, Soraya Regina, Esteve-Sole, Ana, Kanderova, Veronika, García-García, Ana, Lopez-Corbeto, Mireia, Martinez Pomar, Natalia, Martín-Nalda, Andrea, Alsina, Laia, Neth, Olaf, Olbrich, Peter
Publicado 2022

Anti-myeloma efficacy of CAR-iNKT is enhanced with a long-acting IL-7, rhIL-7-hyFc

por O’Neal, Julie, Cooper, Matthew L., Ritchey, Julie K., Gladney, Susan, Niswonger, Jessica, González, L. Sofía, Street, Emily, Haas, Gabriel J., Carter, Alun, Amayta, Parmeshwar N., Gao, Feng, Lee, Byung Ha, Choi, Donghoon, Berrien-Elliott, Melissa, Zhou, Alice, Fehniger, Todd A., Rettig, Mike P., DiPersio, John F.
Publicado 2023

Ponatinib after failure of second‐generation tyrosine kinase inhibitor in resistant chronic‐phase chronic myeloid leukemia

por Kantarjian, Hagop M., Jabbour, Elias, Deininger, Michael, Abruzzese, Elisabetta, Apperley, Jane, Cortes, Jorge, Chuah, Charles, DeAngelo, Daniel J., DiPersio, John, Hochhaus, Andreas, Lipton, Jeffrey, Nicolini, Franck E., Pinilla‐Ibarz, Javier, Rea, Delphine, Rosti, Gianantonio, Rousselot, Philippe, Shah, Neil P., Talpaz, Moshe, Srivastava, Shouryadeep, Ren, Xiaowei, Mauro, Michael
Publicado 2022

Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10‐day decitabine regimen

por Ali, Alaa M., Weisel, Daniel, Gao, Feng, Uy, Geoffrey L., Cashen, Amanda F., Jacoby, Meagan A., Wartman, Lukas D., Ghobadi, Armin, Pusic, Iskra, Romee, Rizwan, Fehniger, Todd A., Stockerl‐Goldstein, Keith E., Vij, Ravi, Oh, Stephen T., Abboud, Camille N., Schroeder, Mark A., Westervelt, Peter, DiPersio, John F., Welch, John S.
Publicado 2017

Proteomic and phosphoproteomic landscapes of acute myeloid leukemia

por Kramer, Michael H., Zhang, Qiang, Sprung, Robert, Day, Ryan B., Erdmann-Gilmore, Petra, Li, Yang, Xu, Ziheng, Helton, Nichole M., George, Daniel R., Mi, Yiling, Westervelt, Peter, Payton, Jacqueline E., Ramakrishnan, Sai M., Miller, Christopher A., Link, Daniel C., DiPersio, John F., Walter, Matthew J., Townsend, R. Reid, Ley, Timothy J.
Publicado 2022

Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial

por Verstovsek, Srdan, Mesa, Ruben A., Gotlib, Jason, Gupta, Vikas, DiPersio, John F., Catalano, John V., Deininger, Michael W. N., Miller, Carole B., Silver, Richard T., Talpaz, Moshe, Winton, Elliott F., Harvey, Jimmie H., Arcasoy, Murat O., Hexner, Elizabeth O., Lyons, Roger M., Paquette, Ronald, Raza, Azra, Jones, Mark, Kornacki, Deanna, Sun, Kang, Kantarjian, Hagop
Publicado 2017

An ‘off-the-shelf’ fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies

por Cooper, Matthew L., Choi, Jaebok, Staser, Karl, Ritchey, Julie K., Devenport, Jessica M., Eckardt, Kayla, Rettig, Michael P., Wang, Bing, Eissenberg, Linda G., Ghobadi, Armin, Gehrs, Leah N., Prior, Julie L., Achilefu, Samuel, Miller, Christopher A., Fronick, Catrina C., O’Neal, Julie, Gao, Feng, Weinstock, David M., Gutierrez, Alejandro, Fulton, Robert S., DiPersio, John F
Publicado 2018

Decitabine salvage for TP53-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy

por Ferraro, Francesca, Gruszczynska, Agata, Ruzinova, Marianna B., Miller, Christopher A., Percival, Mary Elizabeth, Uy, Geoffrey L., Pusic, Iskra, Jacoby, Meagan A., Christopher, Mathew J., Kim, Miriam Y., Westervelt, Peter, Cashen, Amanda F., Schroeder, Mark A., DiPersio, John F., Abboud, Camille N., Wartman, Lukas D., Gao, Feng, Link, Daniel C., Ley, Timothy J., Welch, John S.
Publicado 2022

The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia

por Issa, Ghayas C., Aldoss, Ibrahim, DiPersio, John, Cuglievan, Branko, Stone, Richard, Arellano, Martha, Thirman, Michael J., Patel, Manish R., Dickens, David S., Shenoy, Shalini, Shukla, Neerav, Kantarjian, Hagop, Armstrong, Scott A., Perner, Florian, Perry, Jennifer A., Rosen, Galit, Bagley, Rebecca G., Meyers, Michael L., Ordentlich, Peter, Gu, Yu, Kumar, Vinit, Smith, Steven, McGeehan, Gerard M., Stein, Eytan M.
Publicado 2023

Genomic landscape of TP53-mutated myeloid malignancies

por Abel, Haley J., Oetjen, Karolyn A., Miller, Christopher A., Ramakrishnan, Sai M., Day, Ryan B., Helton, Nichole M., Fronick, Catrina C., Fulton, Robert S., Heath, Sharon E., Tarnawsky, Stefan P., Nonavinkere Srivatsan, Sridhar, Duncavage, Eric J., Schroeder, Molly C., Payton, Jacqueline E., Spencer, David H., Walter, Matthew J., Westervelt, Peter, DiPersio, John F., Ley, Timothy J., Link, Daniel C.
Publicado 2023